Epidemiology of Gastrointestinal Damage Associated with Nonsteroidal Anti-Inflammatory Drugs
- 14 Downloads
Nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with significant upper gastrointestinal (GI) toxicity, with a relative risk of approximately 3. This is supported by evidence drawn from randomised controlled trials [of aspirin (acetylsalicylic acid)], cohort studies and case-control studies. The risk is increased with higher doses of medication, shorter treatment duration and concomitant corticosteroid use. Elderly patients and those with a history of GI illness are also at increased risk. Ibuprofen may be associated with a lower, and piroxicam with a higher, risk of complications. There are only preliminary data regarding an association between NSAIDs and small and large intestinal complications.
Therapeutic alternatives which may confer a lower risk of significant GI toxicity include enteric-coated preparations, non-acetylated salicylates, and NSAIDs taken in conjunction with misoprostol. Epidemiological data regarding these alternatives are sparse.
KeywordsAspirin Misoprostol Nsaid User Gastrointestinal Damage Salsalate
Unable to display preview. Download preview PDF.
- Abeles M, Gordon R, Johnson J, Labowitz R, Lowenstein M, et al. A double-blind multi-investigator study of Trilisate versus acetylsalicylic acid tablets in patients with rheumatoid arthritis: final clinical summary. In Ehrlich (Ed.) The resurgence of salicylates in arthritis therapy, pp. 104–109, Science Media Communications, Norwalk, 1983Google Scholar
- Bollini P, Garcia Rodriguez LA, Gutthann SP, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Archives of Internal Medicine 152: 1289–1295, 1992PubMedCrossRefGoogle Scholar
- Cohen A, Garber HE. Comparison of choline magnesium trisalicylate and acetylsalicylic acid in relation to fecal blood loss. Current Therapeutic Research 23: 187–193, 1978Google Scholar
- Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre. How to read clinical journals IV. To determine etiology or causation. Canadian Medical Association Journal 124: 985–990, 1981Google Scholar
- Goldenberg A, Rudnicki RD, Koonce ML. Clinical comparison of efficacy and safety of choline magnesium trisalicylate and indomethacin in treating osteoarthritis. Current Therapeutic Research 24: 245–260, 1978Google Scholar
- Graham DY, Smith JL, Spjut HJ, Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 95: 327–333, 1988bGoogle Scholar
- Henry DA, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology, in press, 1994Google Scholar
- Lanza FL, Fakouhi D, Rubin A, Davis RE, Rack MF, et al. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol qid in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. American Journal of Gastroenterology 84: 633–636, 1989PubMedGoogle Scholar
- McLaughlin G. Choline magnesium trisalicylate vs. naproxen in rheumatoid arthritis. Current Therapeutic Research 32: 579–585, 1982Google Scholar
- Multicenter Salsalate/Aspirin Comparison Study Group. Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis? Journal of Rheumatology 16: 321–327, 1989Google Scholar